FORM 6-K

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                        REPORT OF FOREIGN PRIVATE ISSUER
                        PURSUANT TO RULE 13a-16 OR 15d-16
                        OF THE SECURITIES EXCHANGE ACT OF
                                      1934

                For the quarterly period ended November 30, 2000

                              Inzeco Holdings Inc.
            ---------------------------------------------------------
                 (Translation of registrant's name into English)

             999 Barton Street, Stoney Creek, Ontario L8E 5H4 Canada
           ----------------------------------------------------------
                    (Address of principal executive offices)

      [Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.

                       Form 20-F  X            Form 40-F
                                -----                     -----



      [Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.

                       Yes           No  X
                            ----        ----

      If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-
                                                   -------------.

      This Form 6-K consists of the second quarter interim report of Inzeco
Holdings Inc. for the period ended November 30, 2000. All references to
dollar amounts in the Financial Statements, unless otherwise indicated, are
to Canadian dollars, presented in accordance with Canadian generally accepted
accounting principles.





INZECO HOLDINGS INC.
(A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Balance Sheets

November 30, 2000 and May 31, 2000
(Unaudited)





                                                              November 30             May 31
                                                             -------------         ---------
                                                                              
 ASSETS

 Current assets:
     Cash and cash equivalents                                $  2,867,635          $ 1,712,725
     Miscellaneous receivable                                       20,126               92,953
     Prepaid expenses                                                8,442                8,442
                                                              ------------          -----------
                                                                 2,896,203            1,814,120

 Fixed assets                                                      476,148              534,481

 Goodwill, net of accumulated amortization
   of $69,392 (2000 - $56,210)                                      39,546               52,728

 Deferred development costs                                              1                    1
                                                              ------------          -----------
                                                              $  3,411,898          $ 2,401,330
                                                              ============          ===========

 LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY)

 Current liabilities:
     Accounts payable                                         $     120,944         $    768,248
     Convertible debentures                                         356,321              349,278
                                                              -------------         ------------
                                                                    477,265            1,117,526
 Shareholders' equity (deficiency):
     Share capital                                                8,373,046            5,613,805
     Equity component of convertible debentures                      10,722               10,722
     Deficit                                                     (5,449,135)          (4,340,723)
                                                              -------------         ------------
                                                                  2,934,633            1,283,804
                                                              -------------         ------------
                                                              $   3,411,898         $  2,401,330
                                                              =============         ============



 See accompanying notes to interim financial statements.


                                       2









 INZECO HOLDINGS INC.
 (A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Statements of Operations and Deficit
Three months ended November 30, 2000 and 1999
(Unaudited)





                                                                  2000                 1999
                                                           -----------          -----------
                                                                          

 Income:
      Interest                                             $    41,200          $     1,376
      Fees and licenses                                              -                    -
                                                           -----------          -----------
                                                                41,200                1,376
 Operating expenses:
      General and administrative                               241,824              134,148
      Other                                                    295,649              192,527
      Depreciation                                              34,266                    -
      Amortization                                               6,591                6,591
      Interest on convertible debenture                         13,764               17,953
      Interest and bank charges                                    228                  119
                                                           -----------          -----------
                                                               592,322              351,338
                                                           -----------          -----------

 Loss for the period                                          (551,122)            (349,962)

 Deficit accumulated during development
   stage, beginning of period

 Deficit accumulated during development
   stage, end of period

 Loss per share                                            $     (0.02)         $     (0.02)
                                                           -----------          -----------
 Weighted average number of shares
   outstanding                                              31,260,541           22,271,253
                                                           ===========          ===========



 See accompanying notes to interim financial statements.


                                        3






 INZECO HOLDINGS INC.
 (A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Statements of Operations and Deficit
Cumulative six months ended November 30, 2000 and 1999
(Unaudited)





                                                                  2000                 1999
                                                           -----------          -----------
                                                                          

 Income:
     Interest                                              $    63,826          $     4,737
     Fees and licenses                                               -                6,077
                                                           -----------          -----------
                                                                63,826               10,814
 Operating expenses:
     General and administrative                                536,583              371,066
     Other                                                     532,634              258,759
     Depreciation                                               68,533                    -
     Amortization                                               13,182               13,182
     Interest on convertible debenture                          20,807               36,105
     Interest and bank charges                                     499                  344
                                                           -----------          -----------
                                                             1,172,238              679,456
                                                           -----------          -----------

 Loss for the period                                        (1,108,412)            (668,642)
 Deficit accumulated during development
   stage, beginning of period                               (4,340,723)          (3,035,316)
                                                           -----------          -----------
 Deficit accumulated during development
   stage, end of period                                    $(5,449,135)         $(3,703,958)
                                                           ===========          ===========
 Loss per share                                            $     (0.04)         $     (0.03)
                                                           ===========          ===========

 Weighted average number of shares
   outstanding                                              29,055,090           22,246,450
                                                           ===========          ===========




 See accompanying notes to interim financial statements.


                                       4






INZECO HOLDINGS INC.
(A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Statements of Cash Flows
Three months ended November 30, 2000 and 1999
(Unaudited)





                                                                  2000                 1999
                                                           -----------          -----------
                                                                         

 Cash provided by (used in):

 Operating activities:
      Loss for the period                                  $ (551,122)         $  (349,962)
      Items not involving cash:
          Interest on convertible debenture                     13,764               17,953
          Amortization                                          40,857                6,591

      Change in non-cash operating working capital:
          Miscellaneous receivable                             100,944               40,860
          Loan receivable                                            -                    -
          Prepaid expenses                                           -                    -
          Accounts payable & accrued liabilities                68,918              130,938
                                                           -----------          -----------
                                                             (326,639)            (154,160)
 Financing activities:
      Issuance of common shares                                  3,000               33,750
      Issuance of special warrants                                   -                    -
      Proceeds from loan payable                                     -                    -
                                                           -----------          -----------
                                                                 3,000               33,750
 Investing activities:
      Purchase of fixed assets                                       -                    -
                                                           -----------          -----------
                                                                     -                    -
                                                           -----------          -----------

 Increase (decrease) in cash and
   cash equivalents                                          (323,639)            (120,410)

 Cash and cash equivalents,
   beginning of period                                       3,191,274              190,444
                                                           -----------          -----------
 Cash and cash equivalents,
   end of period                                           $ 2,867,635         $     70,035
                                                           ===========          ===========




 See accompanying notes to interim financial statements.


                                       5






INZECO HOLDINGS INC.
(A DEVELOPMENT STAGE COMPANY)

Interim Consolidated Statements of Cash Flows
(Expressed in Canadian dollars)

Cumulative six months ended November 30, 2000 and 1999
(Unaudited)




                                                                  2000                  1999
                                                          ------------          ------------
                                                                          

 Cash provided by (used in):

 Operating activities:
      Loss for the period                                 $ (1,108,412)          $  (668,642)
      Items not involving cash:
          Interest on convertible debenture                     20,807                36,105
          Amortization                                          81,715                13,182

      Change in non-cash operating working capital:
          Miscellaneous receivable                              72,827                26,278
          Loan receivable                                            -               (25,000)
          Prepaid expenses                                           -                  (700)
          Accounts payable & accrued liabilities              (661,068)              (11,367)
                                                          ------------           -----------
                                                            (1,594,131)             (630,144)
 Financing activities:
      Issuance of common shares                              2,759,241                33,750
                                                          ------------           -----------
                                                             2,759,241                     -
 Investing activities:
      Purchase of fixed assets                                 (10,200)                    -
                                                          ------------           -----------
                                                               (10,200)                    -
                                                          ------------           -----------
 Increase (decrease) in cash and
   cash equivalents                                          1,154,910              (596,394)
 Cash and cash equivalents,
   beginning of period                                       1,712,725               666,429
                                                          ------------           -----------
 Cash and cash equivalents,
   end of period                                          $  2,867,635           $    70,035
                                                          ============           ===========



 See accompanying notes to interim financial statements.



                                        6





 INZECO HOLDINGS INC.
 (A DEVELOPMENT STAGE COMPANY)

 Notes to Interim Consolidated Statements

 Three months ended November 30, 2000
 (Unaudited)


 1      SIGNIFICANT ACCOUNTING POLICIES:

        These interim financial statements include all adjustments which in the
        opinion of management are necessary in order to make the financial
        statements not misleading. For a full description of accounting policies
        which have been applied on a consistent basis in these interim financial
        statements, except as described in note 2, refer to the Company's annual
        financial statements.


 2.     CHANGE IN ACCOUNTING POLICY:

        Effective January 1, 2000, The Canadian Institute of Chartered
        Accountants ("CICA") changed the accounting standards relating to the
        accounting for income taxes. The CICA's new standard on accounting for
        income taxes adopts the liability method of accounting for future income
        taxes. Under the liability method, future income tax assets and
        liabilities are determined based on "temporary differences" (differences
        between the accounting basis and the tax basis of the assets and
        liabilities), and are measured using the currently enacted, or
        substantively enacted, tax rates and laws expected to apply when these
        differences reverse. A valuation allowance is recorded against any
        future income tax asset if it is more likely than not that the asset
        will not be realized. Income tax expense or benefit is the sum of the
        Company's provision for current income taxes and the difference between
        the opening and ending balances of the future income tax assets and
        liabilities.

        Prior to adoption of this new accounting standard, income tax expense
        was determined using the deferral method. Under this method, deferred
        income tax expense was determined based on "timing differences"
        (difference between the accounting and tax treatment of items of expense
        or income), and were measured using the tax rates in effect in the year
        the differences originated. Certain deferred tax assets, such as the
        benefit of tax losses carried forward, were not recognized unless there
        was virtual certainty that they would be realized.

        The adoption of this standard has had no impact on the Company's
        financial position, results of operations or cash flows.



                                        7






 3.     SHARE CAPITAL:

         (a) On June 14, 2000, the Company completed a private placement of
             4,033,333 special warrants at a subscription price of $0.60 each
             for gross cash proceeds of $2,420,000. Each special warrant is
             convertible into 1 common share or 1.1 common shares, if a receipt
             for the related prospectus is not received by October 15, 2000.
             Costs of arranging the private placement, including agent's
             commissions, is $217,300 plus 201,667 special warrants granted to
             the agent.

             The prospectus was filed on October 12, 2000 and on October 15,
             2000, the special warrants were converted into 4,033,333 common
             shares.


         (b) On October 31, 2000, 15,000 shares were issued for gross proceeds
             of $3,000.

         (c) On May 31, 2000, Inzeco completed a private placement of 2,807,500
             common shares with a subscription price of U.S. $0.40 per share for
             gross proceeds of U.S. $1,123,000 or Cdn. $1,680,570. The shares
             were fully paid, with the proceeds held in trust by the Company's
             escrow agent until June 6, 2000 when the Funds were wired to the
             Company. Costs of arranging the private placement were $23,466. If
             the Company does not have a Registration Statement filed and
             declared effective by the Securities and Exchange Commission in the
             United States by December 31, 2000, the Company will be required to
             issue 1 additional common share for each 10 shares issued under
             this private placement.

             The Registration Statement was not declared effective by December
             31, 2000. Inzeco has not yet issued, for nil consideration, the
             280,750 additional common shares required due to not having the
             Registration Statement filed and declared effective by December 31,
             2000. When these shares are issued, they will be accounted for like
             a stock split with an increase to the number of shares outstanding
             but no change to the value of share capital.

             On November 30, 2000, the Company had 32,871,886 common shares and
             2,710,250 stock options outstanding.

         (d) The potential effects of the issuance of common shares under stock
             option plans, as well as due to common share purchase warrants and
             convertible debentures is not dilutive to the loss per share.


                                       8





                              INZECO HOLDINGS INC.
                       MANAGEMENT DISCUSSION AND ANALYSIS
                                January 31, 2001

The following discussion and analysis assumes the reader is familiar with the
Company's audited consolidated financial statements for the year ending May 31,
2000 and its interim financial statements dated November 30, 2000 and the notes
to the financial statements therein. This discussion and analysis contains
statements that are not historical facts and forward looking statements which
involve risk and uncertainties that could cause actual results to differ
materially from those anticipated by management or inferred by the reader.


OVERVIEW

Inzeco Holdings Inc. is commercializing RTICA(R) brand insulation through its
wholly owned subsidiary, RTICA Inc. RTICA is a competitive, high performance
insulating material made from recycled plastic with improved industrial hygiene
features compared to conventional mineral fiber products such as fiber glass.
During Q2 Fiscal 2001, the Company continued its pre-commercial activities
focusing on preparing for the commercial introduction of RTICA(R) blowing wool
in the insulation contractor market in Canada and the United States. Initial
commercial shipments of blowing wool to contractors are expected in Q4 Fiscal
2001.

Regarding the related building code, the Technical Guide, containing the
specification for blowing wool in Canada has been finalized. As soon as the
plant is running continuously we will request an Evaluation Report, or
certification from the National Research Council completing the building code
process for blowing wool in Canada. This involves both testing of our product
and an ISO like evaluation of our manufacturing, quality assurance and other
systems. We plan to present the Canadian specification with minor additions to
US national building code officials in April. The Company currently has
sufficient test results to secure permission from local building code officials
for market development installations in both Canada and the United States.

Scale up of our production facility in Stoney Creek continues with the addition
of personnel and equipment. We are about half way through our eighteen month
project. Although we are about three months behind in our projected timeline, we
are about $1,000,000 under budget with significant savings against budget in
capital expenditures and all operating categories except for legal and
professional fees for securities work.

Raw material evaluations continue with the successful evaluation of multi
layered colored beverage containers with the one of the newer barrier resins
completed.

A small manufacturing system is being constructed at NRC-Industrial Materials
Institute in Montreal for Research and Development work allowing us to focus on
commercial activities at Stoney Creek. A breakthrough in fiber production
leading to further improvements in orientation and yield and additional product
opportunities has been made. Our second patent application for equipment design
was submitted to the US Patent and Trademark Office in November.

Our shareholders at the National Insulation Contractors Exchange buying group
in the US are impatient for product. We are in daily contact with the members
and will continue to do so until we begin to ship product. Discussions with
other buying groups, distributors and contractors in both Canada and the US are
proceeding and we have a backlog of test houses arranged in Canada and the US
who are waiting for product.



                                        9







FINANCIAL

Operating Expenses for Q2 were substantially higher than the previous comparable
period. The company raised $4.65 million in May and June of 2000 which
significantly improved the company's cash position. Transaction expenses were
about $450,000, not including agent warrants. By comparison, last year we were
conserving cash as we were still arranging financing. Our cash reserve generates
interest income and our only interest expense is for the $360,000 convertible
denture held by Enbridge Inc.

The US Securities Registration process was complicated and the registration
statement was not declared effective until January 9, 2001. As a result, the
company must provide 280,000 shares to the US investors as we missed the
deadline for the SEC declaring the Company's registration statement effective.
However, we are closer to achieving our goal of trading on the Over the Counter
Bulletin Board (OTCBB) in the US and are taking steps to do so.

The company arranged repayable pre commercialization funding from National
Research Council Industrial Research Assistance Program for up to $450,000 in
addition to the R&D contribution it already receives.

The current level of spending on capital equipment and pre commercial costs is
not expected to change significantly over the next quarter. The Company
estimates that it has working capital for approximately 18 months although
working capital required to support pending commercial sales may decrease cash
reserves more than anticipated.



                                       10





                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                       Inzeco Holdings Inc.
                                       ----------------------------------------
                                                          (Registrant)

 Date February 1, 2001                 By: /s/ Robert Stikeman
                                           ------------------------------------
                                           *(Signature) Robert Stikeman,
                                                        Chief Financial Officer



* Print the name and title of the signing officer under his signature.


                                       11